谷歌浏览器插件
订阅小程序
在清言上使用

S1054 TUSCANY-2: A Dose-Ranging Phase IIb Study Evaluating Efficacy and Safety of RO7790121, an Antibody Against Tumor Necrosis Factor-Like Ligand 1A (Anti-Tl1a) in Adults with Moderately to Severely Active Ulcerative Colitis

American Journal of Gastroenterology(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要